Public consultation on proposed amendments to the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS, MARCH 2026
Overview
Scheduling amendments referred to expert advisory committee
This consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the MARCH 2026 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS) and the Joint meeting of ACMS and ACCS.
The closing date for this consultation is close of business 29 January 2026. All submissions received by the deadline will be considered by the delegate before they make an interim decision.
The proposals under consultation are detailed in the public notice of March 2026.
Substances for which public comment is sought:
ACMS:
- First-generation sedating antihistamines
- Melatonin
ACCS:
- Flufenoximacil
- Oxalic Acid
Joint meeting of ACMS-ACCS:
- Methylene blue
Audiences
- Anyone from any background
Interests
- Aboriginal and Torres Strait Islander health
- Advertising
- Advisory bodies and committees
- Alcohol
- Applications and Forms
- Artificial Intelligence (AI)
- Children's health
- Chronic disease
- Clinical trials
- Communicable diseases
- Compliance and enforcement
- COVID-19
- Dental health
- Drugs and substance abuse
- e-Health
- Environmental health
- Fees and payments
- Food standards
- Health insurance
- Health technology
- Hearing
- Hospitals
- Immunisation
- Import and export
- Labelling and packaging
- Learning and development
- Legislation
- Manufacturing
- Medicare
- Mental health
- Non-prescription medicines
- Organ and tissue donation
- Pharmaceutical benefits
- Pharmacovigilance
- Prescription drugs
- Preventative health
- Regulatory policy
- Rural health services
- Safety
- Scheduling/Poisons standard
- Shortages
- Tobacco
- Unique Device Identification (UDI)
- Women's health
Share
Share on Twitter Share on Facebook